Aura Biosciences Inc. (AURA) NASDAQ
$7.09 (0.10) (-1.39%)
Market Cap: $350.99M
As of 04/22/24 04:00 PM EDT. Market closed.
Aura Biosciences Inc. (AURA)
NASDAQ
$7.09
(0.10) (-1.39%)
Market Cap: $350.99M
As of 04/22/24 04:00 PM EDT. Market closed.
Add to Portfolio
at aura biosciences, we are developing a new class of therapies to target and destroy cancer cells selectively, while leaving surrounding tissue unharmed – an approach we call molecular surgery. by safely eliminating cancer locally, we can treat early and transform the lives of people with a wide range of cancers that are poorly managed today. our lead program in ocular melanoma (om), also ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
89
URL
Address
.
PRICE CHART FOR AURA BIOSCIENCES INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$7.19
Days Range
$7.04 - $7.24
52 week range
$5.99 - $13.50
Volume
82,255
Avg. Volume (30 days)
132,353
Market Cap
$350.99M
Dividend Yield
-
P/E
-
Shares Outstanding
49,504,405
Open
-
Previous Close
$7.19
Days Range
$7.04 - $7.24
52 week range
$5.99 - $13.50
Volume
82,255
Avg. Volume (30 days)
132,353
Market Cap
$350.99M
Dividend Yield
-
P/E
-
Shares Outstanding
49,504,405
FINANCIAL STATEMENTS FOR AURA BIOSCIENCES INC
LOADING...
INSIDER TRANSACTIONS FOR AURA BIOSCIENCES INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
de los Pinos Elisabet | See Remarks | Jan 23, 2024 | Sale | $7.64 | 15,853 | 121,141 | 161,438 | Jan 24, 2024, 04:20 PM |
Feder Julie B | Chief Financial Officer | Jan 23, 2024 | Sale | $7.64 | 6,609 | 50,521 | 62,991 | Jan 24, 2024, 04:18 PM |
Johnson David Michael | Director | Nov 08, 2023 | Buy | $7.30 | 10,000 | 73,000 | 75,000 | Nov 09, 2023, 05:02 PM |
Johnson David Michael | Director | Nov 08, 2023 | Buy | $7.30 | 10,000 | 73,000 | 75,000 | Nov 09, 2023, 05:02 PM |
Johnson David Michael | Director | Nov 08, 2023 | Buy | $7.30 | 9,601 | 70,087 | 135,667 | Nov 09, 2023, 05:02 PM |
Johnson David Michael | Director | Nov 07, 2023 | Buy | $7.17 | 94,000 | 673,980 | 65,000 | Nov 09, 2023, 05:02 PM |
Johnson David Michael | Director | Nov 07, 2023 | Buy | $7.17 | 76,000 | 544,920 | 126,066 | Nov 09, 2023, 05:02 PM |
Matrix Capital Management Company, LP | 10% Owner | Nov 09, 2023 | Buy | $9.00 | 1,560,000 | 14,040,000 | 6,922,870 | Nov 09, 2023, 04:35 PM |
de los Pinos Elisabet | See Remarks | Nov 06, 2023 | Option Exercise | $2.74 | 3,800 | 10,412 | 184,740 | Nov 07, 2023, 06:19 PM |
de los Pinos Elisabet | See Remarks | Nov 06, 2023 | Sale | $12.03 | 7,449 | 89,611 | 177,291 | Nov 07, 2023, 06:19 PM |
Feder Julie B | Chief Financial Officer | Nov 06, 2023 | Option Exercise | $2.74 | 3,900 | 10,686 | 73,500 | Nov 07, 2023, 06:09 PM |
Feder Julie B | Chief Financial Officer | Nov 06, 2023 | Sale | $12.07 | 3,900 | 47,054 | 69,600 | Nov 07, 2023, 06:09 PM |
Feder Julie B | Chief Financial Officer | Oct 30, 2023 | Sale | $6.82 | 3,385 | 23,091 | 69,600 | Nov 01, 2023, 06:24 PM |
de los Pinos Elisabet | See Remarks | Oct 30, 2023 | Sale | $6.83 | 9,586 | 65,478 | 180,940 | Nov 01, 2023, 06:21 PM |
Johnson David Michael | Director | Oct 03, 2023 | Buy | $8.27 | 13,500 | 111,663 | 43,500 | Oct 05, 2023, 07:56 PM |
Johnson David Michael | Director | Oct 04, 2023 | Buy | $8.61 | 6,566 | 56,512 | 50,066 | Oct 05, 2023, 07:56 PM |
Johnson David Michael | Director | Jan 06, 2023 | Buy | $10.51 | 904 | 9,501 | 18,000 | Jan 09, 2023, 05:55 PM |
Johnson David Michael | Director | Jan 06, 2023 | Buy | $10.50 | 700 | 7,350 | 18,000 | Jan 09, 2023, 05:55 PM |
Johnson David Michael | Director | Jan 05, 2023 | Buy | $10.00 | 96 | 960 | 17,096 | Jan 09, 2023, 05:55 PM |
Johnson David Michael | Director | Jan 05, 2023 | Buy | $10.00 | 300 | 3,000 | 17,300 | Jan 09, 2023, 05:55 PM |
Johnson David Michael | Director | Dec 28, 2022 | Buy | $9.75 | 2,000 | 19,500 | 17,000 | Dec 30, 2022, 07:01 PM |
Johnson David Michael | Director | Dec 28, 2022 | Buy | $9.75 | 2,000 | 19,500 | 17,000 | Dec 30, 2022, 07:01 PM |
Johnson David Michael | Director | Dec 01, 2022 | Buy | $12.37 | 5,000 | 61,850 | 15,000 | Dec 15, 2022, 06:15 PM |
Johnson David Michael | Director | Dec 01, 2022 | Buy | $12.37 | 5,000 | 61,850 | 15,000 | Dec 15, 2022, 06:15 PM |
Matrix Capital Management Company, LP | 10% Owner | Dec 05, 2022 | Buy | $12.00 | 1,250,000 | 15,000,000 | 5,362,870 | Dec 07, 2022, 04:30 PM |
Feder Julie B | Chief Financial Officer | Oct 31, 2022 | Sale | $12.45 | 2,015 | 25,090 | 24,235 | Nov 02, 2022, 08:39 PM |
Rich Cadmus | See Remarks | Oct 31, 2022 | Sale | $12.45 | 1,672 | 20,813 | 24,578 | Nov 02, 2022, 08:38 PM |
de los Pinos Elisabet | See Remarks | Oct 31, 2022 | Sale | $12.46 | 5,706 | 71,082 | 68,651 | Nov 02, 2022, 08:37 PM |
De Rosch Mark | Chief Operating Officer | Oct 31, 2022 | Sale | $12.46 | 1,115 | 13,890 | 16,385 | Nov 02, 2022, 08:36 PM |
Johnson David Michael | Director | Jun 10, 2022 | Buy | $15.04 | 3,000 | 45,120 | 3,000 | Jun 14, 2022, 09:29 PM |
Johnson David Michael | Director | Jun 13, 2022 | Buy | $13.99 | 20,000 | 279,800 | 30,000 | Jun 14, 2022, 09:29 PM |
Johnson David Michael | Director | Jun 13, 2022 | Buy | $13.99 | 7,000 | 97,930 | 10,000 | Jun 14, 2022, 09:29 PM |
Johnson David Michael | Director | Jun 13, 2022 | Buy | $13.99 | 7,000 | 97,930 | 10,000 | Jun 14, 2022, 09:29 PM |
Johnson David Michael | Director | Jun 10, 2022 | Buy | $15.04 | 10,000 | 150,400 | 10,000 | Jun 14, 2022, 09:29 PM |
Johnson David Michael | Director | Jun 10, 2022 | Buy | $15.04 | 3,000 | 45,120 | 3,000 | Jun 14, 2022, 09:29 PM |
Medicxi Ventures Management (Jersey) Ltd | 10% Owner | Nov 02, 2021 | Buy | $14.00 | 710,000 | 9,940,000 | 2,969,352 | Nov 04, 2021, 05:00 PM |
Matrix Capital Management Company, LP | 10% Owner | Nov 02, 2021 | Buy | $14.00 | 1,785,000 | 24,990,000 | 4,112,870 | Nov 04, 2021, 04:44 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN AURA BIOSCIENCES INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
MATRIX CAPITAL MANAGEMENT COMPANY, LP | 6,922,870 | 0.63% | 29.09% | Growth |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,225,000 | 0.08% | 46.96% | Other |
BLACKROCK INC. | 2,098,745 | 0.00047% | 12.59% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 676,128 | 0.00063% | 28.43% | Other |
PLATINUM INVESTMENT MANAGEMENT LTD | 180,145 | 0.06% | New | Growth At A Reasonable Price, Value |
UBS OCONNOR LLC | 90,000 | 0.06% | 104.55% | Value |
D. E. SHAW & CO., INC. | 60,064 | 0.00047% | New | Other |
ALPS ADVISORS INC | 33,660 | 0.00234% | 19.54% | Other |
RENAISSANCE TECHNOLOGIES LLC | 28,500 | 0.00039% | 111.11% | Other |
CHANGE IN SHARES OUTSTANDING FOR AURA BIOSCIENCES INC
STOCK BUYBACKS FOR AURA BIOSCIENCES INC
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
16.93%
1Q
06/30/2023
17.95%
2Q
03/31/2023
18.17%
3Q
12/31/2022
39.49%
4Q
09/30/2022
52.53%
5Q
06/30/2022
52.64%
6Q
03/31/2022
52.84%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AURA BIOSCIENCES INC
LOADING...